US Patent Issued to GILGAMESH PHARMACEUTICALS on Jan. 27 for "Phenalkylamines and methods of treating mood disorders" (New York Inventor)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,425, issued on Jan. 27, was assigned to GILGAMESH PHARMACEUTICALS INC. (New York).

"Phenalkylamines and methods of treating mood disorders" was invented by Andrew Carry Kruegel (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Phenalkylamines and methods of treating mood disorders with phenalkylamines. Also provided are pharmaceutical compositions that include phenalkylamines."

The patent was filed on June 28, 2021, under Application No. 18/013,776.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&...